International Clinical Trial: LineMatrix(R) Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07733076) titled 'LineMatrix(R) Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement' on July 21.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Shanghai Zhongshan Hospital

Condition: Peripheral Arterial Disease

Intervention: Device: LineMatrix(R) Biological Vascular Graft

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 30, 2026

Target Sample Size: 15

To know more, visit https://clinicaltrials.gov/study/NCT07733076

Published by HT Digital C...